Amarantus Receives Notice of Allowance for Patent Application on MANF
Amarantus Receives Notice of Allowance for U.S. Patent Application Covering Proprietary Compositions of ...
Amarantus BioScience Publishes Positive Parkinson's Phase 2a Data in Brain Journal
Yesterday, biotechnology company Amarantus BioScience Holdings, Inc. ( AMBS-OTC) announced that the clinical ...
Amarantus Acquires Specialized Neuro-Diagnostics Company, DioGenix, Inc.
Lead Product MSPrecise(R): Clinically Validated, First-In-Class Next-Generation Sequencing (NGS) Assay that ...
Amarantus Announces Major Potential Acquisition and 2014 LymPro Test® Launch
Since the publication of our Executive Informational Overview® (EIO) on Amarantus BioScience Holdings, Inc. ...
Biotech Company Amarantus Provides Business Update/Q3 2014 Financial Results
On Monday, November 10, Amarantus Bioscience Holdings, Inc. started off the earnings week by reporting its ...
The Market May Be Down, But Amarantus is Up on Its News
Biotechnology company Amarantus Bioscience Holdings, Inc. (AMBS-OTC) reported this morning that it had ...
Study Data: Amarantus One Step Closer to a Q4 Launch of an Alzheimer's Blood Test
Biotech company Amarantus Bioscience Holdings, Inc. (AMBS-OTC) has reported positive data from its LP-002 ...
Amarantus BioScience Outlines Required Steps for Eltoprazine Trial
Amarantus BioScience Holdings, Inc. (AMBS-OTC) provided investors with an important update today regarding ...
Clinical Trial Finds Link Between Xanax, Valium and Alzheimer's Disease
A new clinical study published Tuesday in the British Medical Journal, identified a possible link between ...
NEW RESEARCH: Amarantus Pursues Novel Blood Test for Alzheimer's and More
Today, Crystal Research Associates has issued a 76-page Executive Informational Overview® (EIO) on California ...